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INTRODUCTION:  Phyllodes  tumours  are  rare ﬁbro-epithelial  lesions.  The  role  of the pathologist  in  the
preoperative  diagnosis  of phyllodes  tumours  of the  breast  is  critical  to appropriate  surgical  planning.  Wide
local  excision  or  mastectomy  with  adequate  margin  remains  the  treatment  of choice.  Local  recurrencevailable online 22 July 2016
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occurs  in approximately  10- 16.1%  of patients  (Wei  et al., 2014)  [1]  and  distant  metastases  occurs  in
6.3–31%  of  patients  with  malignant  phyllodes  tumours  (Wei  et al. (2014),  Chaney  et al.,  1998)  [1,2] but
only  in  4%  of  all  phyllodes  tumours  (Salvador  et al., 1989)  [3]. Emphasis  should  be  given  in early  diagnosis
and  intervention  to decrease  morbidity  and  mortality.
©  2016  The  Author(s).  Published  by Elsevier  Ltd on behalf  of  IJS Publishing  Group  Ltd.  This  is  an  open
access  article  under  the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Case presentation
A 44 year old Indo-Trinidadian female was referred to the Breast
linic of San Fernando General Hospital of Trinidad and Tobago. On
xamination there was a 24 × 20 cm ﬁrm lobulated mobile mass in
er right breast with no skin changes, no nipple discharge and her
xillary lymph nodes were not palpable. She had no associated risk
actors for breast cancer and no family history of breast and ovar-
an cancer. A bilateral mammogram of breast revealed 20 × 20 cm
obulated mass on right breast with architectural distortion and
symmetry (Fig. 1). Colour Doppler image shows increased vascu-
arity of the mass but no speciﬁc features suggestive of malignancy.
 needle core biopsy revealed breast tissue with a stromal fragment
ith occasional mitoses suggestive of phyllodes/ﬁbroadenoma. The
atient was counselled for mastectomy but she refused and sought
elp from alternative remedies despite several attempts at coun-
elling. The patient returned back after one year. At that time, she
as emaciated/malnourished and anaemic with a fungating mass
approximately 50 × 50 cm)  occupying over the entire right chest
all with enlarged prominent cutaneous blood vessels (Fig. 2a,
). The patient had palpable right axillary lymph nodes and her
eft breast examination was normal. A repeat needle core biopsy
evealed a benign phyllodes tumour with extremes infarction. A CT
can of the chest revealed a heterogeneous enhancing mass in right
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reativecommons.org/licenses/by-nc-nd/4.0/).breast with ill- deﬁned deep margin at the RUOQ with few enlarged
axillary lymph nodes with no suspicious features and there were
no obvious chest wall or pulmonary metastasis were noted (Fig. 3).
CT abdomen and pelvis showed no liver and bony metastasis.
Informed consent was  obtained from the patient. Right wide
mastectomy with partial excision of pectoralis major with axillary
lymph nodes sampling (Figs. 4 and 5) and immediate latissimus
dorsi (LD) ﬂap closure (Fig. 6) was  performed. The dissection was
very tedious as the blood vessels were grossly dilated under the
skin. The patient had a successful postop recovery (Fig. 7). Histology
of the specimen revealed a low grade (benign) phyllodes tumour
with scanty mitoses and minimal nuclear atypia (Fig. 8a, b). Six (6)
axillary lymph nodes were identiﬁed with reactive changes and no
metastasis. All resection margins were otherwise negative. The case
was discussed at our MDT  meeting and decision was made for long
term follow up with no further adjuvant therapy.
After several months, the patient was  readmitted with a mas-
sive pleural effusion on the contra-lateral side of the tumour.
Cytology of the pleural ﬂuid revealed malignant cells. The original
histopathology of the specimen was once again reviewed by two
senior pathologists, but failed to diagnose any malignancy. Despite
further treatment patient demised after 6 months from her initial
surgery.
2. DiscussionPhyllodes tumours represent a broad range of ﬁbro-epithelial
diseases. They make up 0.3–0.5% of female breast tumours and have
an incidence of about 2.1 per million [4]. Most of the tumours arise
in women aged between 35 and 55 years, approximately 20 years
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 2. (a) Giant phyllodes tumour with prominent dilated subcutaneous vessels.(b)
The  fungating giant phyllodes tumour. (a, b): The fungating giant phyllodes tumourig. 1. Initial mammogram shows lobulated mass on right breast with architectural
istortion.
ater than ﬁbro-adenoma. The tumour is rarely found in adolescents
nd the elderly [3,5]. It is more prevalent in the Latin American,
hite and Asian populations.
Chelius in 1827 ﬁrst described this tumour [6]. Johannes Muller
as the ﬁrst person to use the term cysto-sarcoma phyllodes. It
as believed to be benign until 1943, when Cooper and Ackerman
eported on the malignant biological potential of this tumour. In
981 the World Health Organization adopted the term phyllodes
umour and as described by Rosen sub-classiﬁed them histologi-
ally as benign, borderline, or malignant according to the features
uch as tumour margins, stromal overgrowth, tumour necrosis,
ellular atypia, and number of mitosis per high power ﬁeld [7].
ecause of limited data, the percentage of benign versus malignant
hyllodes tumours is not well deﬁned. Reports suggest that approx-
mately 85–90% of phyllodes tumours are benign and 10–15% were
alignant [8].
At present time, the exact aetiology of phyllodes tumour and its
elationship with ﬁbro-adenoma are unclear. It has been suggested
hat, in a proportion of ﬁbro-adenomas, a somatic mutation can
esult in a monoclonal proliferation, histologically indistinguish-
ble from the polyclonal element, but with a propensity to local
ecurrence and progression to a phyllodes tumor, which has also
een supported by clonal analysis [9].
Classically, patients present with a ﬁrm, mobile, well deﬁned,
ound, macro-lobulated, and painless mass [10,11]. The median size
f phyllodes tumours is around 4 cm;  however, <10% of tumours
rows larger than 10 cm which are rare and these have been
eﬁned as giant phyllodes tumour and very rarely they can be up
o 48 cm in diameter. In 10–15% cases axillary lymph nodes are
alpable but only <1% had pathological positive nodes. In recent
ears several giant phyllodes tumour have been reported (Hsu et al.,
0 × 25 cm;  Tarun et al., 50 × 25.2 cm;  Juliana Alves De Suza et al.,
4 × 10 cm;  Ramesh sarvanandan et al., 40 × 35 cm;  Junaid Nabi
t al., 9 × 8 cm;  Mohammed A. Sbeih et al., 25 × 20 cm;  Tapanutt
ikhitmaskul et al., 20 × 20m; Dong Xia et al., 47.5 × 37 cm;  Rumi
hajotia et al., 24 × 22 cm;  Banno A. et al., 30 cm)  [12–21].
Our patient presented with one of the largest giant phyllodes
umour in the English literature, measuring 50 × 50 cm.  It was a
ungating mass, ﬁxed to the skin, but mobile over the underlyingwith prominent dilated subcutaneous vessels.
muscle and her axillary lymph nodes were palpable. There were
multiple hugely dilated feeding blood vessels to the tumour, which
can be a challenge surgically and have to be looked for especially
subcuatenous veins and perforating intercostal vessels.
A variety of techniques have been utilized to improve the
pre-operative diagnosis of phyllodes tumours, such as ultrasound,
mammogram, MRI  and core needle biopsy. Ultrasound and mam-
mography are the most commonly used ﬁrst line investigation for
this disease. There are no pathognomonic mammographic or ultra-
sound features of phyllodes tumour [22].
Core tissue biopsy represents the preferred means of pre-
operative diagnosis for giant breast tumours with a sensitivity of
99% and negative predictive value and positive predictive value 93%
and 83%, respectively [23].
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Fig. 3. CT chest showing heterogeneous enhancing mass in right breast with ill-
deﬁned deep margin.
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Fig. 5. Phyllodes tumor after excision.
Fig. 6. LD ﬂap to cover the anterior chest wall.Fig. 4. Chest wall after excision of phyllodes tumor.
Surgical management of the phyllodes tumour includes either
reast conserving surgery or mastectomy with or without recon-
truction [24–26]. Most experts currently advocate that surgeons
btain at least 1 cm margins on primary excision or re-excision of a
umour removed with close margins, as long as the tumour to breast
ize will permit [2,3,10,27,28]. Mastectomy should be reserved for
arger tumours between 5 and 10 cm in diameter [11–21,24,25]
nd should be considered in recurrent tumours, and especially of
he malignant tumours [3].
Closure of wound after excision of a giant phyllodes tumor
emains a great challenge for the surgeons. There is no contraindi-
ation to immediate reconstruction after mastectomy in cases of
iant phyllodes tumour, and this decision can be made solely basedupon patient preference. Most often immediate reconstruction of
the chest wall was  performed with prosthetic implant or chest wall
are covered with splits skin graft, marlex mesh or latissimus dorsi
muscular/myo-cutaneous ﬂap; if the fascia or muscle is inﬁltrated
[10–21,25,29–31].
The role of adjuvant radiotherapy and chemotherapy remains
uncertain, but consideration can be given for their use in cases of
malignant phyllodes tumours [2,32,33].
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. Conclusion
The diagnosis of phyllodes tumor should be entertained in all
atients presenting with progressive enlargement of breast lump.
mphasis should be given on proper health education on breast
ancer and the negative consequences of alternative or delayed
reatment. Excision should be done as soon as possible, as unneces-
ary delay can leads to diseases progression and increase morbidity
nd mortality.
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